Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells
Moiez Ali(Emory University), Kris C. Wood(Duke University), Christine E. Eyler(Duke University), Collin M. Blakely(University of California, San Francisco), Helena A. Yu(Memorial Sloan Kettering Cancer Center), Haley M. Hutchinson(Duke University), Min Lu(Vanderbilt University), Caroline E. McCoach(Memorial Sloan Kettering Cancer Center), Omar Lopez(Duke University), Christopher F. Bassil(Duke University), Carolyn Glass(Buck Institute for Research on Aging), Ryan S. Soderquist(Duke University), Hazel X. Ang(Duke University), Aaron N. Hata(Harvard University), Christina J. Falcon(Memorial Sloan Kettering Cancer Center), D. Lucas Kerr(UCSF Helen Diller Family Comprehensive Cancer Center), Trever G. Bivona(University of California, San Francisco)
Cited by 45
Related Papers
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642